BIOS — Bioservo Technologies AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK1.60m
- -SEK17.28m
- SEK9.64m
Annual cashflow statement for Bioservo Technologies AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.2 | -23.2 | -26.3 | -34.7 | -50.6 |
| Depreciation | |||||
| Non-Cash Items | — | — | 0.315 | -0.121 | 0.074 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.13 | -6.52 | 5.38 | -3.7 | -3.09 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.8 | -25.9 | -16.6 | -34.4 | -50.6 |
| Capital Expenditures | -4.8 | -1.05 | -1.2 | -1.81 | -1.05 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | -0.04 | 0.04 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.8 | -1.09 | -1.16 | -1.81 | -1.05 |
| Financing Cash Flow Items | — | -5.98 | -0.879 | -1.92 | -2.57 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.272 | 58.4 | 13.4 | 35.1 | 25.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -21.3 | 31.4 | -4.37 | -1.04 | -26.5 |